SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 375.96-1.8%Nov 14 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sense who wrote (175907)8/7/2021 8:49:43 AM
From: TobagoJack  Read Replies (1) of 217823
 
More <<rumblings … not priced-in>>

haaretz.com
Israel's COVID Rhetoric Turns Grim, Reflecting Real Trouble
Delta variant smashed all of Israel's working assumptions, but talk of a fourth lockdown ignores its many negative ramifications
Amos Harel
Aug. 6, 2021
The Israeli government this week sharply changed its tone, and apparently also its policy, in regard to the spread of the coronavirus.
The moderate measures, which also were adopted late, were replaced by warnings about a fourth wave, horror scenarios of thousands of seriously ill and talk of a definite lockdown during the Jewish religious festivals in September – a lockdown that would last for six to eight weeks.


And worse, that the experiment is not going as expected, but ‘they’ want folks to go for a third boost. Should the effect be LT cumulative and loitering in character, … not-good, for all and especially the young, should some unknown and unknowable threshold be crossed as we go forward, boost after boost, as the Swedish ‘they’ reckoned Message 33430274

english.alarabiya.net

Pfizer’s COVID-19 vaccine may be linked to eye inflammation: Israeli study

06 August ,2021: 01:14 AM GST

Pfizer’s COVID-19 vaccine may be linked to a form of eye inflammation called uveitis, according to an Israeli study.

The Jerusalem Post reported that Habot-Wilner, head of the Uveitis Service at the hospital, found that 21 people who had received two shots of the Pfizer vaccine developed uveitis, a form of eye inflammation, within one to 14 days after receiving their first shot or within one day to one month after the second.

The research was conducted at multiple medical centers across Israel.

“All the patients in the study met the World Health Organization and Naranjo criteria linking the onset of uveitis to the vaccination,” Habot-Wilner said.

The study has shown that most cases were mild. All uveitis cases were able to be treated with topical corticosteroids and eye drops for pupil dilation.

“Only one case worsened after receiving the second dose,” according to Habot-Wilner, but she said that with appropriate treatment the disease had been was resolved.

The study added that at the end of the follow-up period it was found that in all eyes visual acuity improved and disease was completely resolved.

The study concluded that is recommended for people with or without a history of uveitis to get vaccinated.

Habot-Wilner stressed that developing uveitis from vaccination, in general, is “quite rare,” but that eye inflammation has been associated with other vaccines.

“It is very uncommon, but if you do feel something is wrong with your eyes, if you have pain, redness, or vision deterioration, please go and visit your eye doctor,” she said.

Sent from my iPad
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext